By Regulatory Approvals — FDA Approves Oveporexton, First Orexin Receptor Agonist for Narcolepsy Type 1 Patient Care Online
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. August 7, 2026.